Evidence map›Paper›PMID 32952952›Full record

ArticleIranian journal of basic medical sciences2020

Bioinformatics prediction and experimental validation of VH antibody fragment interacting with

Hediyeh Rafighdoust, Shahrzad Ahangarzadeh, Fatemeh Yarian, Ramezan Ali Taheri, Arezou Lari, Mojgan Bandehpour, Mona Salahshoor Dahr

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of basic medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. An update on antiviral antibody-based biopharmaceuticals.International immunopharmacology · 2020
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Hediyeh RafighdoustDepartment of Biology, School of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Shahrzad AhangarzadehInfectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Fatemeh YarianCellular & Molecular Biology Research Center Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ramezan Ali TaheriNanobiotechnology Research Center, Baqiyatallah University of Medical Sciences,Tehran, Iran.
Arezou LariSystems Biomedicine, Pasteur Institute of Iran, Tehran, Iran.
Mojgan BandehpourCellular & Molecular Biology Research Center Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mona Salahshoor DahrDepartment of Biology, Faclty of Basic Science, Islamic Azad University Islamshahr Branch, Islamshahr, Iran.
Shahid Beheshti University of Medical Sciences · IRBaqiyatallah University of Medical Sciences · IRIsfahan University of Medical Sciences · IRIslamic Azad University Islamshahr Branch · IRIslamic Azad University, Science and Research Branch · IRPasteur Institute of Iran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe previously conducted an MATERIALS AND

methodsIn this study, at first, the three-dimensional structure of VH fragment was simulated by Kotai Antibody Builder web server. By using ClusPro 2.0 web server, the 3D structure of the soluble form of fHbp (PDB: 2KC0) was docked to the modeled VH fragment to extract the structure of the complex's binding. Molecular dynamics (MD) simulation was carried out using GROMACS 4.5.3 package for 65 ns. Secondly, coding sequence of VH fragment was cloned separately and expressed in

resultsImportant amino acids involved in antigen- antibody interaction were identified by analyzing the fHbp-VH complex. The ability of the VH antibody fragment to bind and detect fHbp antigen has been confirmed by the results of

conclusionThese results showed that this small fragment of antibody could be used for designing diagnostic kits.

Indexed as

CloningHeavy chain variableModelingMolecular dockingSurface plasmon resonance

Identifiers

PMID32952952
PMCPMC7478258
OpenAlexW3049140992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.